Allakos (ALLK) announced topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria. In the CSU cohort, 34 adult ...

Adagene (ADAG) announced updated clinical data from ADG126 in microsatellite stable colorectal cancer, MSS CRC, at the ASCO Gastrointestinal ...

Mediar Therapeutics is planning to launch a Phase 2 clinical trial in the first half of 2025 to test its IPF therapy MTX-463.

Eight of the remaining hostages set to be released by Hamas in the first phase of a ceasefire agreement with Israel are dead, ...

The FDA has approved the investigational new drug application of 225Ac-SSO110, allowing for the start of a phase 1/2 trial in patients with extensive-stage small cell lung cancer and Merkel cell ...

100 avatar icons of Ranma 1/2 anime remake characters are now available online. The icons were shared to celebrate January 2, 2025, which can be written as 1/2 as per Japanese date notations.

Chemical manufacturer Stardust Power Inc. announced that it broke ground on its $1.2 billion lithium refinery at the ...

Manchester City scored three second half goals to come back from the brink of elimination and advance to the UEFA Champions ...

After decades of looking, researchers have seen a string of atoms go through a 1D phase change so elusive that it could only happen inside a quantum simulator. “One motivation [for our ...

Ocugen, Inc. announced the positive 2-year safety and efficacy update for the Phase 1/2 OCU400 clinical trial for the treatment of early to advanced retinitis pigmentosa (RP) in pediatric and adult ...

Beam Therapeutics is set to present positive and significant data from the BEACON Phase 1/2 clinical trial of BEAM-101 at a major conference, enhancing visibility and credibility within the ...

Ahead of the new year, Australia’s financial markets regulators convened a gathering of superannuation fund executives in ...